In conclusion, the recognition of a peculiar phenotypic pattern of late-onset RP due to c.425A>G mutations in the CRX gene with a relatively mild clinical picture may be important for directing molecular testing, providing correct genetic counseling, and properly suggesting possible therapeutic options. The gene discussed is CRX; the disease is retinitis pigmentosa 1.